Hypertension drug developer Mineralys Therapeutics files for $100M IPO
Andranik Hakobyan Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering. The biotech company didn't ...
Andranik Hakobyan Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering. The biotech company didn't ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.